AVDL
Price
$15.34
Change
+$0.01 (+0.07%)
Updated
Sep 26 closing price
Capitalization
1.49B
37 days until earnings call
ELAN
Price
$19.61
Change
+$0.69 (+3.65%)
Updated
Sep 26 closing price
Capitalization
9.74B
43 days until earnings call
Interact to see
Advertisement

AVDL vs ELAN

Header iconAVDL vs ELAN Comparison
Open Charts AVDL vs ELANBanner chart's image
Avadel Pharmaceuticals
Price$15.34
Change+$0.01 (+0.07%)
Volume$1.02M
Capitalization1.49B
Elanco Animal Health
Price$19.61
Change+$0.69 (+3.65%)
Volume$5.01M
Capitalization9.74B
AVDL vs ELAN Comparison Chart in %
Loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. ELAN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a StrongBuy and ELAN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (AVDL: $15.34 vs. ELAN: $19.61)
Brand notoriety: AVDL and ELAN are both notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVDL: 76% vs. ELAN: 63%
Market capitalization -- AVDL: $1.49B vs. ELAN: $9.74B
AVDL [@Pharmaceuticals: Generic] is valued at $1.49B. ELAN’s [@Pharmaceuticals: Generic] market capitalization is $9.74B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 2 TA indicator(s) are bullish while ELAN’s TA Score has 3 bullish TA indicator(s).

  • AVDL’s TA Score: 2 bullish, 5 bearish.
  • ELAN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а -5.31% price change this week, while ELAN (@Pharmaceuticals: Generic) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

AVDL is expected to report earnings on Nov 05, 2025.

ELAN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.74B) has a higher market cap than AVDL($1.49B). ELAN YTD gains are higher at: 61.932 vs. AVDL (45.956). ELAN has higher annual earnings (EBITDA): 1.45B vs. AVDL (7.87M). ELAN has more cash in the bank: 539M vs. AVDL (81.5M). AVDL has less debt than ELAN: AVDL (2.73M) vs ELAN (4.21B). ELAN has higher revenues than AVDL: ELAN (4.48B) vs AVDL (221M).
AVDLELANAVDL / ELAN
Capitalization1.49B9.74B15%
EBITDA7.87M1.45B1%
Gain YTD45.95661.93274%
P/E RatioN/A22.28-
Revenue221M4.48B5%
Total Cash81.5M539M15%
Total Debt2.73M4.21B0%
FUNDAMENTALS RATINGS
AVDL vs ELAN: Fundamental Ratings
AVDL
ELAN
OUTLOOK RATING
1..100
778
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
9379
PRICE GROWTH RATING
1..100
3839
P/E GROWTH RATING
1..100
4287
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVDL's Valuation (82) in the Medical Specialties industry is in the same range as ELAN (93) in the Agricultural Commodities Or Milling industry. This means that AVDL’s stock grew similarly to ELAN’s over the last 12 months.

AVDL's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that AVDL’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's SMR Rating (79) in the Agricultural Commodities Or Milling industry is in the same range as AVDL (93) in the Medical Specialties industry. This means that ELAN’s stock grew similarly to AVDL’s over the last 12 months.

AVDL's Price Growth Rating (38) in the Medical Specialties industry is in the same range as ELAN (39) in the Agricultural Commodities Or Milling industry. This means that AVDL’s stock grew similarly to ELAN’s over the last 12 months.

AVDL's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for ELAN (87) in the Agricultural Commodities Or Milling industry. This means that AVDL’s stock grew somewhat faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLELAN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
62%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZNOV26.370.02
+0.09%
Innovator Equity Defined Prt ETF -1YrNov
RAYS10.09N/A
N/A
Global X Solar ETF
VLT11.22-0.02
-0.18%
Invesco High Income Trust II
SOXS5.31-0.03
-0.56%
Direxion Daily Semicondct Bear 3X ETF
DAPP20.58-0.20
-0.96%
VanEck Digital Trfmt ETF

AVDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVDL has been loosely correlated with RMTI. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if AVDL jumps, then RMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+0.07%
RMTI - AVDL
33%
Loosely correlated
+4.10%
ELAN - AVDL
31%
Poorly correlated
+3.65%
EBS - AVDL
28%
Poorly correlated
+1.95%
HLN - AVDL
27%
Poorly correlated
+1.15%
RDY - AVDL
27%
Poorly correlated
+0.42%
More

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+3.65%
VTRS - ELAN
53%
Loosely correlated
+0.32%
ZTS - ELAN
48%
Loosely correlated
+1.68%
PAHC - ELAN
39%
Loosely correlated
+2.02%
EBS - ELAN
38%
Loosely correlated
+1.95%
AMRX - ELAN
36%
Loosely correlated
+1.56%
More